Close Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

Baidu Ventures

Investor type Venture Capital

Overview

Unlock datapoints

Portfolio analytics

Team

Investments

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.
Total investments 147
Average round size
info
The average size of a deal this fund participated in
$15M
Portfolio companies 110
Rounds per year 24.50
Lead investments 34
Follow on index
info
How often the fund supports its portfolio startups at next rounds
0.25
Exits 2
Key employees 4
Stages of investment
Early Stage Venture

Areas of investment

  • Artificial Intelligence
  • Health Care
  • Information Technology
  • Machine Learning
  • Biotechnology
Summary

Baidu Ventures appeared to be the VC, which was created in 2016. The fund was located in Asia if to be more exact in China. The main office of represented VC is situated in the Beijing.

The typical case for the fund is to invest in rounds with 3-4 participants. Despite the Baidu Ventures, startups are often financed by Legend Star, Shunwei Capital, ZhenFund. The meaningful sponsors for the fund in investment in the same round are Shunwei Capital, Tsingyuan Ventures, Sequoia Capital China. In the next rounds fund is usually obtained by Shunwei Capital, Lenovo Capital and Incubator Group (LCIG), Legend Capital.

The higher amount of exits for fund were in 2019. The average startup value when the investment from Baidu Ventures is 10-50 millions dollars. The real fund results show that this VC is 19 percentage points more often commits exit comparing to other companies. The fund is constantly included in 13-24 investment rounds annually. Opposing the other organizations, this Baidu Ventures works on 28 percentage points less the average amount of lead investments. The usual things for fund are deals in the range of 10 - 50 millions dollars. The important activity for fund was in 2018.

The overall number of key employees were 3.

Moreover, a startup needs to be at the age of 2-3 years to get the investment from the fund. Among the most popular portfolio startups of the fund, we may highlight Taihe Music Group, Insilico Medicine, Atomwise. We can highlight the next thriving fund investment areas, such as Artificial Intelligence, Biotechnology. The fund has no exact preference in a number of founders of portfolio startups. In case when startup counts 5+ of the founder, the chance for it to get the investment is meager. For fund there is a match between the country of its foundation and the country of its the most frequent investments - China.

Read more

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of Baidu Ventures:
Typical Co-investors
Baidu Ventures is more likely to invest in rounds together with the following funds:
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after Baidu Ventures:

Funds with similar focus

Funds from China
Funds with similar focus located in China:
Funds with the same geo focus
Funds with similar geography of portfolio companies:
Funds doing lead investments
Funds with similar focus acting as lead investors:

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

Movio

Software
Video
Web Apps
$9M08 Nov 2022 Los Angeles, California, United States

Ruishun Bio

Biopharma
Biotechnology
Life Science
$9M17 Aug 2022 -

JHETECH

Automotive
Hardware
Lighting
21 Jul 2022 Shanghai, Shanghai, China

Degron Therapeutics

$22M09 Jun 2022 Shanghai, Shanghai, China

Qingyun Zhitong

Artificial Intelligence
Big Data
Chemical
Intelligent Systems
Internet of Things
Manufacturing
$15M06 Jun 2022 Beijing, Beijing, China

CubeWorks

Biopharma
Computer
Electronics
Information Technology
Internet of Things
Sensor
$2M01 Jun 2022 Ann Arbor, Michigan, United States

Gritworld

Artificial Intelligence
Computer
Enterprise
Information Technology
26 Apr 2022 Shanghai, China

Qingmei Electric

Manufacturing
Smart Home
02 Apr 2022 Cixi, Zhejiang, China

Pixso

Cloud Computing
Software
UX Design
$15M28 Mar 2022 Shenzhen, Guangdong, China
News
Insilico Medicine Raises $255 Million in Series C Financing Led by Warburg Pincus

– Insilico Medicine announced that it has closed a $255m Series C.
– The financing led by Warburg Pincus, and participated by current investors including Qiming Venture Partners, Pavilion Capital, Eight Roads Ventures, Lilly Asia Ventures, Sinovation Ventures, BOLD Capital Partners, Formic Ventures, Baidu Ventures, and new investors including CPE, OrbiMed, Mirae Asset Capital, B Capital Group, Deerfield Management, Maison Capital, Lake Bleu Capital, President International Development Corporation, Sequoia Capital China and Sage Partners.
– The financing will be used to progress Insilico Medicine’s current therapeutic programs into human clinical trials, initiate multiple new programs for novel and difficult targets, and further develop its AI and drug discovery capabilities.

Engine Biosciences Announces $43 Million Series A Round to Decipher Genetic Codes for New Medicines Through Machine Learning and Next-Generation Combinatorial Genetics

– Engine Biosciences announced the successful completion of an oversubscribed $43m Series A funding round.
– Engine identifies errors in the complex genetic codes of diseases, fixing them with precise therapeutic solutions.
– This round was led by Polaris Partners and also included new investors Invus and one of the world’s premier institutional investors, based in Singapore.
– Existing investors also participated in the Series A, which included 6 Dimensions Capital, WuXi AppTec, DHVC, EDBI, Baidu Ventures, Vectr Ventures, Goodman Capital, WI Harper, and Nest.Bio.
– Amy Schulman, Managing Partner at Polaris Partners, has joined the Engine Biosciences Board of Directors.

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Baidu Ventures?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!

Wait!
You can raise money with us faster

Get matched with relevant funds

Find decision makers data

Connect with investors by email

Remind me later
...and save more than 200 hours*
*-Our recommendation and outreach system saves up to 200 hours of founder time on fundraising for seed and series A+ startups
We use LinkedIn only to verify your account. We don't import or message your contacts, nor post on your behalf.
By creating an account, you agree to our Terms of Service and Privacy Policy.
Crunchbase icon

Content report

The following text will be sent to our editors: